PUBLICATIONS · 20970380
High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Lancet Oncol
- Publication date
- 2010 Nov
- First author
- Thiel E
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Lancet Oncol. 2010 Nov;11(11):1011-2. doi: 10.1016/S1470-2045(10)70234-5.
- note
- Source null
- related pmid
- 20970379
- relationship
- Comment in
- citation
- Lancet Oncol. 2011 Feb;12(2):118-9; author reply 119-20. doi: 10.1016/S1470-2045(11)70018-3.
- note
- Source null
- related pmid
- 21277546
- relationship
- Comment in
Authors and identifiers
- name
- Thiel E
- type
- Author
- name
- Korfel A
- type
- Author
- name
- Martus P
- type
- Author
- name
- Kanz L
- type
- Author
- name
- Griesinger F
- type
- Author
- name
- Rauch M
- type
- Author
- name
- Röth A
- type
- Author
- name
- Hertenstein B
- type
- Author
- name
- von Toll T
- type
- Author
- name
- Hundsberger T
- type
- Author
- name
- Mergenthaler HG
- type
- Author
- name
- Leithäuser M
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Thiel E
- type
- Author
- name
- Korfel A
- type
- Author
- name
- Martus P
- type
- Author
- name
- Kanz L
- type
- Author
- name
- Griesinger F
- type
- Author
- name
- Rauch M
- type
- Author
- name
- Röth A
- type
- Author
- name
- Hertenstein B
- type
- Author
- name
- von Toll T
- type
- Author
- name
- Hundsberger T
- type
- Author
- name
- Mergenthaler HG
- type
- Author
- name
- Leithäuser M
- type
- Author
- bibliography ids
- nci-bib-c0079f520dc6db7759124d2b
- book metadata
- content sha256
- 2fc4d6816137172379fbf39819480a976cf0755ff18ad4fa3ae64cf30db32811
- document type
- citation
- dois
- 10.1016/S1470-2045(10)70229-1
- electronic publication date
- display
- 2010 Oct 20
- precision
- day
- year
- 2010
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:20970380
- immutable id
- pubmed:20970380@2fc4d6816137172379fbf39819480a976cf0755ff18ad4fa3ae64cf30db32811
- journal
- abbreviation
- Lancet Oncol
- issn electronic
- 1474-5488
- issn print
- 1470-2045
- issue
- 11
- name
- The Lancet. Oncology
- nlm unique id
- 100957246
- pages
- 1036-47
- volume
- 11
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Lancet Oncol. 2010 Nov;11(11):1011-2. doi: 10.1016/S1470-2045(10)70234-5.
- note
- Source null
- related pmid
- 20970379
- relationship
- Comment in
- citation
- Lancet Oncol. 2011 Feb;12(2):118-9; author reply 119-20. doi: 10.1016/S1470-2045(11)70018-3.
- note
- Source null
- related pmid
- 21277546
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 20970380
- provenance
- batch id
- 10a38257e12e9ed1867a
- provider
- NCBI PubMed ESummary
- record sha256
- 0143f04e5d7edb2d28302deb742160c413409c64864f47a8c2874e7a8cba852f
- response sha256
- 84c4808ca38b35d999cfdf809eb088835175ab38d71586c626096d677096bbcc
- retrieved at
- 2026-09-09T23:46:35.793530+00:00
- publication date
- display
- 2010 Nov
- precision
- month
- year
- 2010
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
Preserved source evidence · Not medical advice
Triangle